New drug combo shows promise in relieving pain, symptoms
A recent clinical study, conducted at the University of Bath in England with women of reproductive age, demonstrated great potential of a new drug combination. The two drugs are E2MATE – created in the university’s Department of Pharmacy & Pharmacology – and norethindrone acetate, or traditional progesterone.
Researchers must test the drug combination further in human trials to confirm that it will be an effective treatment of…
Exercise has been shown to transiently suppress inflammation in an animal model of rheumatic disease, bolstering evidence to support the theory that regular physical activity is beneficial for patients with the disease. “Exercise can be a very potent therapeutic intervention to control inflammatory diseases, but unfortunately today it is underutilized in clinical practice,” said study author Dr. Nicholas Young from The Ohio State University Wexner Medical Center, Columbus, Ohio, US. “[In our…
A new University of Iowa study further supports an inescapable message: caregivers have a profound influence -- good or bad -- on the emotional state of individuals with Alzheimer's disease. Patients may not remember a recent visit by a loved one or having been neglected by staff at a nursing home, but those actions can have a lasting impact on how they feel. The findings of this study are published in the September 2014 issue of the journal Cognitive and Behavioral Neurology. "Our findings…
What kind of end-of-life care do you want? Don’t leave the burden of such decisions on your loved ones. Make a living will, which will speak for you when you are unable to, says lawyer Lyn Boxall. About two years ago, I answered a phone call from my sister. She lives in my home town, Adelaide in South Australia, and I’ve lived in Singapore for many years. “Mum was found unconscious on the floor of her bathroom this morning and now nothing she’s saying is making any…
Childhood obesity can have a harmful effect on the body in a variety of ways. Obese children are more likely to have : High blood pressure and high cholesterol, which are risk factors for cardiovascular disease (CVD). In one study, 70% of obese children had at least one CVD risk factor, and 39% had two or more. Increased risk of impaired glucose tolerance, insulin resistance and type 2 diabetes. Breathing problems, such as sleep apnea, and asthma. Joint problems and musculoskeletal…
It may not seem like much, but for Maya, the daily battle over the bath is a sign of further deterioration as her 69-year-old mother slips deeper into her dementia, her personality changing, her memories fading, and simple everyday tasks becoming insurmountable hurdles. http://www.hindustantimes.com/lifestyle/wellness/world-alzheimer-s-day-lack-of-help-care-in-india-for-patients/article1-1266659.aspx
In India it is considered shameful to send an elderly relative to a nursing home; instead domestic workers often from rural areas with no education - care for older people in their homes. Complicating matters even further is a lack of geriatric training for doctors in India, the absence of home health care services.. http://newoldage.blogs.nytimes.com/2013/04/05/caregiving-from-another-continent/?_php=true&_type=blogs&_php=true&_type=blogs&smid=fb-share&_r=1&
York University researchers say a simple test that combines thinking and movement can help to detect heightened risk for developing Alzheimer's disease in a person, even before there are any telltale behavioural signs of dementia. "We included a task which involved moving a computer mouse in the opposite direction of a visual target on the screen, requiring the person's brain to think before and during their hand movements," says Sergio in the School of Kinesiology & Health Science. "This…
Gilead Sciences has authorized several generic drug companies in India to sell its $1,000-a-day Hepatitis C pill for a fraction of the price in developing countries like Honduras, Vietnam and South Africa. It signed licensing deals with seven generic pharmaceutical companies that make drugs in India, including Ranbaxy, Cipla and Mylan to sell generic versions of Sovaldi in 91 developing countries. http://online.wsj.com/articles/gilead-to-allow-cheaper-hepatitis-c-drug-1410779963
